Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Summary of publications:
Publications (original articles or review articles) published in 2020 from OUS - Section for Cancer Cytogenetics
6 publications found
Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment
Mol Oncol (in press)
Chromosome Translocation t(14;21)(q11;q22) Activates Both OLIG1 and OLIG2 in Pediatric T-cell Lymphoblastic Malignancies and May Signify Adverse Prognosis
Cancer Genomics Proteomics, 17 (1), 41-48
Chronic Expanding Hematoma with a t(11;19)(q13;q13) Chromosomal Translocation
Anticancer Res, 40 (1), 97-100
FOS-ANKH and FOS-RUNX2 Fusion Genes in Osteoblastoma
Cancer Genomics Proteomics, 17 (2), 161-168
An Unbalanced Chromosome Translocation Between 7p22 and 12q13 Leads to ACTB-GLI1 Fusion in Pericytoma
Anticancer Res, 40 (3), 1239-1245
Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors